Search Results for 'hcv patients'
hcv patients published presentations and documents on DocSlides.
HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC
by jovita
Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Ya...
Management of HCV in Co-Infected Patients
by danika-pritchard
Marie-Louise Vachon, MD, . MSc. Division of . Inf...
Role of harm reduction in HCV prevention in France: from r
by tatiana-dople
Bruno Spire & Patrizia Carrieri. How to reduc...
HCV Screening and Linkage to Care
by alexa-scheidler
Program in a Pharmacy Setting. Conveying . the Ur...
Is it possible? HCV Elimination
by yoshiko-marsland
Objectives. Define elimination as it relates to i...
HepCare Europe No-one gets left behind: addressing the hidden burden of HCV related advanced liver disease in PWID in the community
by cheryl-pisano
HepCare Europe No-one gets left behind: address...
Future HCV Treatment Paradigms
by kittie-lecroy
Mark Sulkowski, MD . Professor of Medicine. Medic...
Update on the HCV Antiviral Pipeline
by natalia-silvester
Todd S. Wills, MD. SPNS HCV Treatment Expansion I...
Access to antiviral drugs for treating HCV for HIV-positive
by yoshiko-marsland
AIDS 2016 | 18-22 July 2016 | Durban, South A...
Care of the Treatment-naive Patient With HCV/HIV Coinfection
by cheryl-pisano
. Case. 47-Year-Old . Man With Asymptomatic HIV ...
![Treat To Prevent – Millennials, Drugs and Hepatitis C [HCV]](https://thumbs.docslides.com/738712/treat-to-prevent-millennials-drugs-and-hepatitis-c-hcv.jpg)
Treat To Prevent – Millennials, Drugs and Hepatitis C [HCV]
by danika-pritchard
Strategies To Identify and Advance PWID HCV Patie...
HCV Clinical Management TRAINER(S)
by danika-pritchard
IAPAC African Regional Capacity-Building Hub. Bas...
HCV Clinical Management TRAINER(S)
by trish-goza
IAPAC African Regional Capacity-Building Hub. Bas...
Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence
by briana-ranney
Sofosbuvir + Ribavirin to Prevent Post-Transplan...
HIV-HCV Coinfection in the era of effective antiviral therapy
by mia
Mark Sulkowski, . MD. Professor of Medicine. Medic...
The Role of Diagnostics in the Management of HCV and HIV
by zoe
Presented by: Thomas E. Burgess, PhD, DABCC, FAACC...
Treatment of Hepatitis C in patients with
by tatyana-admore
thalassaemia. . Where . are we now?. Telaprevir ....
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
by kittie-lecroy
Interim Analysis of a French Multicenter Compassi...
Out With the Old and In With the New, Again?
by test
Out With the Old, In With the New. Current Standa...
Advances in Hepatitis C Identification and Treatment
by giovanna-bartolotta
Developed by Camilla S. Graham, MD, BIDMC, 5/5/15...
HEPATITIS C VIRUS REINFECTION IN PEOPLE WHO INJECT DRUG (PW
by ellena-manuel
G. . Ntetskas. , V. . Papastergiou. , L. . Skorda...
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
by lois-ondreau
Sameh W. Boktor, MD, MPH. Medical Epidemiologist....
National Viral Hepatitis Roundtable
by ellena-manuel
HCV Baby Boomer Screening . and . Linkage to Care...
Resistance to Direct Acting Antiviral Therapy
by tawny-fly
Resistance to HCV DAAs: What is the threat level...
Taking Steps to Improve the Management
by mitsue-stanley
of Chronic HCV. This educational program and spea...
Updates in Treatment of Hepatitis C
by cheryl-pisano
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Updates in Treatment of Hepatitis C
by myesha-ticknor
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Hepatitis C: A New Era In Treatment And Cure
by myesha-ticknor
Adam . Deising. , DO. LCDR MC USN. Director of . ...
C-EDGE Co-Infected: Phase 3 Study of
by giovanna-bartolotta
C-EDGE Co-Infected: Phase 3 Study of Grazoprevi...